Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Randomized, Double-Masked Clinical Trial to Assess the Efficacy and Safety of Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% Compared to Placebo in the Treatment of Inflammation and Pain Associated With Cataract Surgery
Conditions
Interventions
Clobetasol Propionate
Vehicle
Locations
18
United States
Walman Eye Center
Sun City, Arizona, United States
Inland Eye Specialists
Hemet, California, United States
United Medical Research Institute
Inglewood, California, United States
Visionary Eye Institute
Newport Beach, California, United States
North Bay Eye
Petaluma, California, United States
Levenson Eye Associates
Jacksonville, Florida, United States
Start Date
June 4, 2020
Primary Completion Date
April 14, 2021
Completion Date
April 14, 2021
Last Updated
December 22, 2022
NCT07452770
NCT06979752
NCT07362043
NCT06060041
NCT07325188
NCT07305987
Lead Sponsor
Salvat
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions